基於 NGS 的 RNA-seq 廣泛應用於標準和非傳統應用中複雜而全面的基因組洞察。對更好的基於測序的診斷的日益增長的需求推動了新型測序技術的發展。因此，對高通量定序儀和便攜式設備等技術的需求激增。基於NGS的RNA-seq市場正在成長，原因有很多，包括RNA-seq產品技術的發展、RNA-seq相對於微陣列技術的優勢、研究活動的快速擴展、RNA-seq獎項的增加以及對精準醫療的高度需求。
Frequently Asked Questions
The market is segmented based on Global NGS-Based RNA-Sequencing Market Segmentation, By Product and Services (RNA Sequencing Platforms and Consumables, Sample Preparation Products, RNA Sequencing Services, Data Analysis, Storage and Management),Technology (Sequencing By Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing), Application (Expression Profiling Analysis, Small RNA Sequencing, De Novo Transcriptome Assembly, Variant Calling and Transcriptome Epigenetics), End User (Research and Academia, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End Users) – Industry Trends and Forecast to 2032
.
The Global Ngs Based Rna Sequencing Market size was valued at USD 4.21 USD Billion in 2024.
The Global Ngs Based Rna Sequencing Market is projected to grow at a CAGR of 19.9% during the forecast period of 2025 to 2032.
The major players operating in the market include Illumina Inc. ,Thermo Fischer Scientific Inc. ,Oxford Nanopore Technologies plc AGilent TechnologiesInc. ,BGI ,PerkinElmer Inc. ,QIAGEN ,Eurofins Scientific ,F. Hoffmann-La Roche Ltd ,Takara Bio Inc. ,GENEWIZInc. ,Hamilton Company ,Macrogen Inc. ,Zymo Research Corporation ,Tecan Trading AG .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
